AI assistant
Sending…
Ascletis Pharma Inc. — Share Issue/Capital Change 2018
Jul 31, 2018
50081_rns_2018-07-30_6d6c35a8-2a30-4dc5-a5bb-9b6183a5a2a6.htm
Share Issue/Capital Change
Open in viewerOpens in your device viewer
IPO Allotment Results
![]() |
ASCLETIS PHARMA INC. (01672) |
![]() |
![]() |
![]() |
Cover |
![]() |
Summary |
![]() |
Results of applications made by applicants using White Application Forms and White Form eIPO |
![]() |
The following are the results of successful applications using White Application Forms and White Form eIPO. Applicants who have not provided their identification document numbers are not shown |
| Identification document number(s) (A6096363 to Z9023276) | |
![]() |
Results of applications using yellow application forms through designated CCASS broker/custodian participants |
![]() |
The following are the results of successful applications using yellow application forms through designated CCASS broker/custodian participants. Applicants who have not provided their identification document numbers are not shown |
| Identification document number(s) (16492996 to Z8056561) | |
![]() |
There were no wholly or partially successful applicants for applications made by CCASS Investor Participants using yellow application forms. |
![]() |
Results of applications under the Hong Kong public offering by electronic application instructions given to HKSCC |
![]() |
The following are the results of successful applications made by giving electronic application instructions to HKSCC. Applicants who have not provided their identification document numbers are not shown |
| Identification document number(s) (0000523 to Z9909428) | |
![]() |
Collection / posting of share certificates and refund cheques |
More from Ascletis Pharma Inc.
Transaction in Own Shares
2026
Jun 2
Governance Information
2026
Jun 2
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 29
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 7
